Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

Cairo University (CU)

Status: Completed

Conditions: Anesthesia Morbidity

Treatments: Other: Hydroxyethylstarch resuscitation; Other: Albumin resuscitation; Drug: Hydroxyethylstarch 6%; Drug: Albumin 5%

Study type: Interventional

Funder types: Other

Identifiers

NCT03306914

Albumin versus starch

Details and patient eligibility

About

In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.

Enrollment: 120 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• end stage renal disease, for living donor renal transplantation

Exclusion criteria

• severe cardiac or hepatic dysfunction, re-transplantation, coagulopathy

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

120 participants in 2 patient groups

Albumin group

Active Comparator group

Description:

Albumin resuscitation Albumin 5%

Treatment:

Drug: Albumin 5%

Other: Albumin resuscitation

Hydroxyethylstarch group

Experimental group

Description:

Hydroxyethylstarch resuscitation Hydroxyethylstarch 6%

Treatment:

Drug: Hydroxyethylstarch 6%

Other: Hydroxyethylstarch resuscitation